Literature DB >> 8910980

Population-based case control study of folic acid supplementation during pregnancy.

A E Czeizel1, M Tóth, M Rockenbauer.   

Abstract

Previous studies have demonstrated that periconceptional folic acid/multivitamin supplementation reduced the occurrence of neural tube defects. A case control analysis has been conducted in the dataset of the Hungarian Case Control Surveillance of Congenital Abnormalities, 1980-1991. In the study period, 54.9% of 30,663 pregnant women who had healthy babies (negative control group) were supplemented with high doses (in general 2 x 3 mg) of folic acid per day. In those 17,300 pregnant women who had offspring with congenital abnormalities, the rate of folic acid supplementation was 50.4%. Exposure histories: preconceptional, I, II, III, and IV-IX postconceptional months were determined by record reviews and questionnaire assessment. The case control pair analysis showed a significant protection after folic acid supplementation during the critical period of cardiovascular defects, neural tube defects, cleft lip with or without cleft palate and posterior cleft palate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910980     DOI: 10.1002/(SICI)1096-9926(199606)53:6<345::AID-TERA5>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  31 in total

Review 1.  Inflammatory bowel disease in pregnancy.

Authors:  E M Alstead
Journal:  Postgrad Med J       Date:  2002-01       Impact factor: 2.401

Review 2.  Preconception care: a systematic review.

Authors:  Carol C Korenbrot; Alycia Steinberg; Catherine Bender; Sydne Newberry
Journal:  Matern Child Health J       Date:  2002-06

3.  Is folic acid a risk factor for oral clefts?

Authors:  Andrew E Czeizel
Journal:  Eur J Epidemiol       Date:  2013-11-21       Impact factor: 8.082

4.  Nested case-control study of one-carbon metabolites in mid-pregnancy and risks of cleft lip with and without cleft palate.

Authors:  Gary M Shaw; Stein Emil Vollset; Suzan L Carmichael; Wei Yang; Richard H Finnell; Henk Blom; Per M Ueland
Journal:  Pediatr Res       Date:  2009-11       Impact factor: 3.756

Review 5.  Genetic basis of congenital cardiovascular malformations.

Authors:  Seema R Lalani; John W Belmont
Journal:  Eur J Med Genet       Date:  2014-04-30       Impact factor: 2.708

6.  Maternal hypertension with nifedipine treatment associated with a higher risk for right-sided obstructive defects of the heart: a population-based case-control study.

Authors:  Melinda Csáky-Szunyogh; Attila Vereczkey; Balázs Gerencsér; Andrew E Czeizel
Journal:  Heart Asia       Date:  2014-01-23

7.  Folic acid rivals methylenetetrahydrofolate reductase (MTHFR) gene-silencing effect on MEPM cell proliferation and apoptosis.

Authors:  Wen-Lin Xiao; Min Wu; Bing Shi
Journal:  Mol Cell Biochem       Date:  2006-07-11       Impact factor: 3.396

8.  Folate-related gene polymorphisms as risk factors for cleft lip and cleft palate.

Authors:  James L Mills; Anne M Molloy; Anne Parle-McDermott; James F Troendle; Lawrence C Brody; Mary R Conley; Christopher Cox; Faith Pangilinan; David J A Orr; Michael Earley; Eamon McKiernan; Ena C Lynn; Anne Doyle; John M Scott; Peadar N Kirke
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2008-09

Review 9.  Nongenetic risk factors and congenital heart defects.

Authors:  Sonali S Patel; Trudy L Burns
Journal:  Pediatr Cardiol       Date:  2013-08-21       Impact factor: 1.655

10.  118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects.

Authors:  Gary M Shaw; Wei Lu; Huiping Zhu; Wei Yang; Farren B S Briggs; Suzan L Carmichael; Lisa F Barcellos; Edward J Lammer; Richard H Finnell
Journal:  BMC Med Genet       Date:  2009-06-03       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.